Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single-Dose, Single-Treatment, Single-Period Safety and Bioavailability Study of Fexofenadine Hydrochloride Topical Lotion 1% in Healthy, Adult, Male Human Subjects

NCT05461456 is registered in ClinicalTrials.gov with OrchestratePharma GmbH as lead sponsor.

NCT NCT05461456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05461456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single-Dose, Single-Treatment, Single-Period Safety and Bioavailability Study of Fexofenadine Hydrochloride Topical Lotion 1% in Healthy, Adult, Male Human Subjects
Lead sponsor
OrchestratePharma GmbH
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2022
Completion date
October 16, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, atopic dermatitis eczema, atopic rash, eczema, pruritus, psoriasis, psoriasis vulgaris, rash, skin inflammation, skin rash, urticaria, urticaria chronic